Global Candidiasis Drug Supply, Demand and Key Producers, 2024-2030

Description

The global Candidiasis Drug market size is expected to reach $ 1638.7 million by 2030, rising at a market growth of 4.6% CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The standard recommended dose for most Candida infections is fluconazole at 800 mg as the loading dose, followed by fluconazole at a dose of 400 mg/d either intravenously or orally for at least 2 weeks of therapy after a demonstrated negative blood culture result or clinical signs of improvement.

This report studies the global Candidiasis Drug demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Candidiasis Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Candidiasis Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Candidiasis Drug total market, 2019-2030, (USD Million)
Global Candidiasis Drug total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Candidiasis Drug total market, key domestic companies and share, (USD Million)
Global Candidiasis Drug revenue by player and market share 2019-2024, (USD Million)
Global Candidiasis Drug total market by Type, CAGR, 2019-2030, (USD Million)
Global Candidiasis Drug total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Candidiasis Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Perrigo, J & J, Pfizer, Bristol-Myers Squibb, Effik, Teva, Sanofi and Cisen Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Candidiasis Drug market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Candidiasis Drug Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Candidiasis Drug Market, Segmentation by Type
    Oral
    External Use
    Other

Global Candidiasis Drug Market, Segmentation by Application
    Hospital
    Retail Pharmacy
    Other

Companies Profiled:
    Bayer
    Perrigo
    J & J
    Pfizer
    Bristol-Myers Squibb
    Effik
    Teva
    Sanofi
    Cisen Pharmaceutical
    Kingyork Group

Key Questions Answered
1. How big is the global Candidiasis Drug market?
2. What is the demand of the global Candidiasis Drug market?
3. What is the year over year growth of the global Candidiasis Drug market?
4. What is the total value of the global Candidiasis Drug market?
5. Who are the major players in the global Candidiasis Drug market?

Table of Contents

1 Supply Summary
    1.1 Candidiasis Drug Introduction
    1.2 World Candidiasis Drug Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Candidiasis Drug Total Market by Region (by Headquarter Location)
        1.3.1 World Candidiasis Drug Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Candidiasis Drug Market Size (2019-2030)
        1.3.3 China Candidiasis Drug Market Size (2019-2030)
        1.3.4 Europe Candidiasis Drug Market Size (2019-2030)
        1.3.5 Japan Candidiasis Drug Market Size (2019-2030)
        1.3.6 South Korea Candidiasis Drug Market Size (2019-2030)
        1.3.7 ASEAN Candidiasis Drug Market Size (2019-2030)
        1.3.8 India Candidiasis Drug Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Candidiasis Drug Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Candidiasis Drug Major Market Trends

2 Demand Summary
    2.1 World Candidiasis Drug Consumption Value (2019-2030)
    2.2 World Candidiasis Drug Consumption Value by Region
        2.2.1 World Candidiasis Drug Consumption Value by Region (2019-2024)
        2.2.2 World Candidiasis Drug Consumption Value Forecast by Region (2025-2030)
    2.3 United States Candidiasis Drug Consumption Value (2019-2030)
    2.4 China Candidiasis Drug Consumption Value (2019-2030)
    2.5 Europe Candidiasis Drug Consumption Value (2019-2030)
    2.6 Japan Candidiasis Drug Consumption Value (2019-2030)
    2.7 South Korea Candidiasis Drug Consumption Value (2019-2030)
    2.8 ASEAN Candidiasis Drug Consumption Value (2019-2030)
    2.9 India Candidiasis Drug Consumption Value (2019-2030)

3 World Candidiasis Drug Companies Competitive Analysis
    3.1 World Candidiasis Drug Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Candidiasis Drug Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Candidiasis Drug in 2023
        3.2.3 Global Concentration Ratios (CR8) for Candidiasis Drug in 2023
    3.3 Candidiasis Drug Company Evaluation Quadrant
    3.4 Candidiasis Drug Market: Overall Company Footprint Analysis
        3.4.1 Candidiasis Drug Market: Region Footprint
        3.4.2 Candidiasis Drug Market: Company Product Type Footprint
        3.4.3 Candidiasis Drug Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Candidiasis Drug Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Candidiasis Drug Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Candidiasis Drug Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Candidiasis Drug Consumption Value Comparison
        4.2.1 United States VS China: Candidiasis Drug Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Candidiasis Drug Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Candidiasis Drug Companies and Market Share, 2019-2024
        4.3.1 United States Based Candidiasis Drug Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Candidiasis Drug Revenue, (2019-2024)
    4.4 China Based Companies Candidiasis Drug Revenue and Market Share, 2019-2024
        4.4.1 China Based Candidiasis Drug Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Candidiasis Drug Revenue, (2019-2024)
    4.5 Rest of World Based Candidiasis Drug Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Candidiasis Drug Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Candidiasis Drug Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Candidiasis Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Oral
        5.2.2 External Use
        5.2.3 Other
    5.3 Market Segment by Type
        5.3.1 World Candidiasis Drug Market Size by Type (2019-2024)
        5.3.2 World Candidiasis Drug Market Size by Type (2025-2030)
        5.3.3 World Candidiasis Drug Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Candidiasis Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Retail Pharmacy
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Candidiasis Drug Market Size by Application (2019-2024)
        6.3.2 World Candidiasis Drug Market Size by Application (2025-2030)
        6.3.3 World Candidiasis Drug Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Bayer
        7.1.1 Bayer Details
        7.1.2 Bayer Major Business
        7.1.3 Bayer Candidiasis Drug Product and Services
        7.1.4 Bayer Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Bayer Recent Developments/Updates
        7.1.6 Bayer Competitive Strengths & Weaknesses
    7.2 Perrigo
        7.2.1 Perrigo Details
        7.2.2 Perrigo Major Business
        7.2.3 Perrigo Candidiasis Drug Product and Services
        7.2.4 Perrigo Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Perrigo Recent Developments/Updates
        7.2.6 Perrigo Competitive Strengths & Weaknesses
    7.3 J & J
        7.3.1 J & J Details
        7.3.2 J & J Major Business
        7.3.3 J & J Candidiasis Drug Product and Services
        7.3.4 J & J Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 J & J Recent Developments/Updates
        7.3.6 J & J Competitive Strengths & Weaknesses
    7.4 Pfizer
        7.4.1 Pfizer Details
        7.4.2 Pfizer Major Business
        7.4.3 Pfizer Candidiasis Drug Product and Services
        7.4.4 Pfizer Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Pfizer Recent Developments/Updates
        7.4.6 Pfizer Competitive Strengths & Weaknesses
    7.5 Bristol-Myers Squibb
        7.5.1 Bristol-Myers Squibb Details
        7.5.2 Bristol-Myers Squibb Major Business
        7.5.3 Bristol-Myers Squibb Candidiasis Drug Product and Services
        7.5.4 Bristol-Myers Squibb Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Bristol-Myers Squibb Recent Developments/Updates
        7.5.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
    7.6 Effik
        7.6.1 Effik Details
        7.6.2 Effik Major Business
        7.6.3 Effik Candidiasis Drug Product and Services
        7.6.4 Effik Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Effik Recent Developments/Updates
        7.6.6 Effik Competitive Strengths & Weaknesses
    7.7 Teva
        7.7.1 Teva Details
        7.7.2 Teva Major Business
        7.7.3 Teva Candidiasis Drug Product and Services
        7.7.4 Teva Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Teva Recent Developments/Updates
        7.7.6 Teva Competitive Strengths & Weaknesses
    7.8 Sanofi
        7.8.1 Sanofi Details
        7.8.2 Sanofi Major Business
        7.8.3 Sanofi Candidiasis Drug Product and Services
        7.8.4 Sanofi Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Sanofi Recent Developments/Updates
        7.8.6 Sanofi Competitive Strengths & Weaknesses
    7.9 Cisen Pharmaceutical
        7.9.1 Cisen Pharmaceutical Details
        7.9.2 Cisen Pharmaceutical Major Business
        7.9.3 Cisen Pharmaceutical Candidiasis Drug Product and Services
        7.9.4 Cisen Pharmaceutical Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Cisen Pharmaceutical Recent Developments/Updates
        7.9.6 Cisen Pharmaceutical Competitive Strengths & Weaknesses
    7.10 Kingyork Group
        7.10.1 Kingyork Group Details
        7.10.2 Kingyork Group Major Business
        7.10.3 Kingyork Group Candidiasis Drug Product and Services
        7.10.4 Kingyork Group Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Kingyork Group Recent Developments/Updates
        7.10.6 Kingyork Group Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Candidiasis Drug Industry Chain
    8.2 Candidiasis Drug Upstream Analysis
    8.3 Candidiasis Drug Midstream Analysis
    8.4 Candidiasis Drug Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Candidiasis Drug Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Candidiasis Drug Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Candidiasis Drug Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Candidiasis Drug Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Candidiasis Drug Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Candidiasis Drug Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Candidiasis Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Candidiasis Drug Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Candidiasis Drug Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Candidiasis Drug Players in 2023
    Table 12. World Candidiasis Drug Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Candidiasis Drug Company Evaluation Quadrant
    Table 14. Head Office of Key Candidiasis Drug Player
    Table 15. Candidiasis Drug Market: Company Product Type Footprint
    Table 16. Candidiasis Drug Market: Company Product Application Footprint
    Table 17. Candidiasis Drug Mergers & Acquisitions Activity
    Table 18. United States VS China Candidiasis Drug Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Candidiasis Drug Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Candidiasis Drug Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Candidiasis Drug Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Candidiasis Drug Revenue Market Share (2019-2024)
    Table 23. China Based Candidiasis Drug Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Candidiasis Drug Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Candidiasis Drug Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Candidiasis Drug Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Candidiasis Drug Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Candidiasis Drug Revenue Market Share (2019-2024)
    Table 29. World Candidiasis Drug Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Candidiasis Drug Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Candidiasis Drug Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Candidiasis Drug Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Candidiasis Drug Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Candidiasis Drug Market Size by Application (2025-2030) & (USD Million)
    Table 35. Bayer Basic Information, Area Served and Competitors
    Table 36. Bayer Major Business
    Table 37. Bayer Candidiasis Drug Product and Services
    Table 38. Bayer Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Bayer Recent Developments/Updates
    Table 40. Bayer Competitive Strengths & Weaknesses
    Table 41. Perrigo Basic Information, Area Served and Competitors
    Table 42. Perrigo Major Business
    Table 43. Perrigo Candidiasis Drug Product and Services
    Table 44. Perrigo Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Perrigo Recent Developments/Updates
    Table 46. Perrigo Competitive Strengths & Weaknesses
    Table 47. J & J Basic Information, Area Served and Competitors
    Table 48. J & J Major Business
    Table 49. J & J Candidiasis Drug Product and Services
    Table 50. J & J Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. J & J Recent Developments/Updates
    Table 52. J & J Competitive Strengths & Weaknesses
    Table 53. Pfizer Basic Information, Area Served and Competitors
    Table 54. Pfizer Major Business
    Table 55. Pfizer Candidiasis Drug Product and Services
    Table 56. Pfizer Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Pfizer Recent Developments/Updates
    Table 58. Pfizer Competitive Strengths & Weaknesses
    Table 59. Bristol-Myers Squibb Basic Information, Area Served and Competitors
    Table 60. Bristol-Myers Squibb Major Business
    Table 61. Bristol-Myers Squibb Candidiasis Drug Product and Services
    Table 62. Bristol-Myers Squibb Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Bristol-Myers Squibb Recent Developments/Updates
    Table 64. Bristol-Myers Squibb Competitive Strengths & Weaknesses
    Table 65. Effik Basic Information, Area Served and Competitors
    Table 66. Effik Major Business
    Table 67. Effik Candidiasis Drug Product and Services
    Table 68. Effik Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Effik Recent Developments/Updates
    Table 70. Effik Competitive Strengths & Weaknesses
    Table 71. Teva Basic Information, Area Served and Competitors
    Table 72. Teva Major Business
    Table 73. Teva Candidiasis Drug Product and Services
    Table 74. Teva Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Teva Recent Developments/Updates
    Table 76. Teva Competitive Strengths & Weaknesses
    Table 77. Sanofi Basic Information, Area Served and Competitors
    Table 78. Sanofi Major Business
    Table 79. Sanofi Candidiasis Drug Product and Services
    Table 80. Sanofi Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Sanofi Recent Developments/Updates
    Table 82. Sanofi Competitive Strengths & Weaknesses
    Table 83. Cisen Pharmaceutical Basic Information, Area Served and Competitors
    Table 84. Cisen Pharmaceutical Major Business
    Table 85. Cisen Pharmaceutical Candidiasis Drug Product and Services
    Table 86. Cisen Pharmaceutical Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Cisen Pharmaceutical Recent Developments/Updates
    Table 88. Kingyork Group Basic Information, Area Served and Competitors
    Table 89. Kingyork Group Major Business
    Table 90. Kingyork Group Candidiasis Drug Product and Services
    Table 91. Kingyork Group Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 92. Global Key Players of Candidiasis Drug Upstream (Raw Materials)
    Table 93. Candidiasis Drug Typical Customers
List of Figure
    Figure 1. Candidiasis Drug Picture
    Figure 2. World Candidiasis Drug Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Candidiasis Drug Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Candidiasis Drug Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Candidiasis Drug Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Candidiasis Drug Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Candidiasis Drug Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Candidiasis Drug Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Candidiasis Drug Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Candidiasis Drug Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Candidiasis Drug Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Candidiasis Drug Revenue (2019-2030) & (USD Million)
    Figure 13. Candidiasis Drug Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Candidiasis Drug Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Candidiasis Drug by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Candidiasis Drug Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Candidiasis Drug Markets in 2023
    Figure 27. United States VS China: Candidiasis Drug Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Candidiasis Drug Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Candidiasis Drug Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Candidiasis Drug Market Size Market Share by Type in 2023
    Figure 31. Oral
    Figure 32. External Use
    Figure 33. Other
    Figure 34. World Candidiasis Drug Market Size Market Share by Type (2019-2030)
    Figure 35. World Candidiasis Drug Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 36. World Candidiasis Drug Market Size Market Share by Application in 2023
    Figure 37. Hospital
    Figure 38. Retail Pharmacy
    Figure 39. Other
    Figure 40. Candidiasis Drug Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Companies Mentioned

Bayer
Perrigo
J & J
Pfizer
Bristol-Myers Squibb
Effik
Teva
Sanofi
Cisen Pharmaceutical
Kingyork Group